WAVE Clinical Platform vs ContaCT
AI Verdict
Choose WAVE Clinical Platform if…
Choose WAVE Clinical Platform if your primary objective is continuous, proactive patient surveillance across a broad hospital population to prevent adverse events. This system is ideal for providing early warnings of patient deterioration up to six hours in advance, leveraging always-on remote monitoring and predictive analytics to enhance overall patient safety and clinical decision support.
View WAVE Clinical Platform →Choose ContaCT if…
Choose ContaCT by Viz.ai if your organization needs to accelerate the detection and streamline care coordination for specific acute conditions such as stroke, pulmonary embolism, or intracranial hemorrhage. This AI-powered platform excels at rapidly alerting specialists, facilitating secure communication, and optimizing workflows to ensure timely treatment for time-sensitive diagnoses.
View ContaCT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | WAVE Clinical Platform | ContaCT |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based |
| Deployment | Software platform, leverages existing hospital IT infrastructure, client-server architecture, web-enabled devices. | Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ContaCTViz.ai (Tool B) offers a simple, streamlined interface with a strong focus on mobile accessibility for specialists, including high-fidelity 3D image viewing and HIPAA-compliant team communication, which are critical for acute care workflows. While WAVE Clinical Platform (Tool A) offers mobile compatibility and customizable alarms, specific details on its user experience are less prominent in available information, and search results were often conflated with other 'Wave' products.
Clinical Value
ContaCTBoth tools offer significant clinical value with FDA clearances. However, Viz.ai (Tool B) demonstrates a more direct and quantified impact on time-sensitive acute conditions, with studies showing improved door-to-groin times for stroke patients and higher diagnostic accuracy compared to competitors. WAVE Clinical Platform (Tool A) provides valuable early warning for general patient deterioration, but specific, quantified outcome improvements are less detailed in the provided information.
Pricing & Value
ContaCTViz.ai (Tool B) offers greater transparency regarding its pricing model, explicitly stating it is subscription-based and tiered, with clear HIPAA compliance and BAA availability. In contrast, WAVE Clinical Platform (Tool A) requires direct vendor contact for all pricing and compliance details, which can create uncertainty for potential buyers.
Enterprise Readiness
ContaCTViz.ai (Tool B) demonstrates superior enterprise readiness with its deployment in over 1,700 hospitals globally, indicating proven scalability and robust integration capabilities with existing PACS and EHR systems. Its cloud-based architecture and explicit HIPAA/BAA compliance further solidify its suitability for large healthcare organizations, whereas Tool A lacks comparable documented widespread adoption.
Innovation
ContaCTWhile WAVE Clinical Platform (Tool A) was a pioneer as the 'first FDA-cleared AI patient surveillance system,' Viz.ai (Tool B) demonstrates broader and ongoing innovation. Viz.ai has secured multiple FDA clearances for over 50 AI algorithms across various acute conditions and has developed a comprehensive care coordination platform that extends beyond detection to include automated chart summarization and guideline-based recommendations.
Support & Docs
ContaCTViz.ai (Tool B) provides dedicated customer resources, including user guides (for EU) and a 'Viz Academy' for training, indicating a structured approach to support and documentation. The company also mentions '24/7 monitoring and support' in relation to its cloud services. In contrast, specific details regarding support and documentation for WAVE Clinical Platform (Tool A) are not readily available in the provided information or general web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | WAVE Clinical Platform | ContaCT |
|---|---|---|
| Tool Name | WAVE Clinical Platform | ContaCT |
| Company | Excel Medical Electronics | Viz.AI |
| Primary Function | FDA-cleared AI patient surveillance system that uses predictive algorithms to provide early warning of patient deterioration, integrating with EMRs and mobile devices to enhance clinical decision support and patient safety. | AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows, helping ensure patients receive timely treatment. |
| Key Feature Focus | Predictive analytics for patient deterioration (e.g., Visensia Safety Index), early warning of patient deterioration (up to 6 hours in advance). | AI-powered disease detection (LVO, ICH, HCM, PE, Aneurysm), real-time AI-powered alerts and notifications. |
| Integration Capabilities | Integration with Electronic Medical Records (EMR), mobile device compatibility. | Integration with PACS and EHR systems, mobile application for specialists. |
Videos
Demos, reviews, and walkthroughs featuring WAVE Clinical Platform and ContaCT.